Page 2 - Al Kildani News Today : Breaking News, Live Updates & Top Stories | Vimarsana

ACADIA Pharmaceuticals Inc (NASDAQ:ACAD) Q4 2023 Earnings Call Transcript

ACADIA Pharmaceuticals Inc. misses on earnings expectations. Reported EPS is $0.28 EPS, expectations were $0.32. ACADIA Pharmaceuticals Inc.

United statesUnited kingdomMark schneyerParag meswaniCharles duncanTessa romeroJoel beattyAl kildaniSteve davisDoug williamsonDavid hoangBrendan teehanGregory renzaAshwani vermaCorporate communicationsAmerican epilepsy society

Acadia Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Operating Overview

Acadia Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Operating Overview
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Jenniferj rhodesKimberlyj manhardJessica tieszenAl kildaniDeb kazenelsonSteve davisExchange commissionCompany updatesAcadia pharmaceuticalsAcadia pharmaceuticals incChief executiveExecutive vice presidentChief legal officerSenior vice presidentGlobal strategic planningDrug administration

Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Deb kazenelsonAl kildaniJessica tieszenCompensation committeeAcadia pharmaceuticals incAcadia pharmaceuticalsNasdaq listing rule

Acadia Pharmaceuticals to Announce Fourth Quarter and Full Year 2023 Financial Results on February 27, 2024

Acadia Pharmaceuticals to Announce Fourth Quarter and Full Year 2023 Financial Results on February 27, 2024
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Al kildaniDeb kazenelsonJessica tieszenAcadia pharmaceuticals incAcadia pharmaceuticals

Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Jessica tieszenAl kildaniDeb kazenelsonAcadia pharmaceuticals incCompensation committeeAcadia pharmaceuticalsNasdaq listing rule